Fiel, Milky Jane .

HRN: 12-73-07  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2025
LEVOFLOXACIN 500MG (TAB)
06/04/2025
06/11/2025
PO
500 MG/TAB
OD
KLEBSIELLA PNEUMONIAE INFECTION
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: